FierceBiotech 26. Feb. 2026 Accent halts solid tumor trial over adverse events, pivots to other lead cancer program
FierceBiotech 25. Feb. 2026 Worried Trump's MFN push will ‘destroy biotech innovation,’ midsize companies form coalition to fight back
FierceBiotech 25. Feb. 2026 Charles River sells manufacturing and discovery businesses to fulfill promised pivot
FierceBiotech 25. Feb. 2026 Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess
FierceBiotech 25. Feb. 2026 After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
FierceBiotech 25. Feb. 2026 GSK pays $950M in cash for Canadian biotech and its Winrevair-like blood pressure drug
FierceBiotech 25. Feb. 2026 After 230% deal size explosion, China is no longer the 'bargain basement' for biopharma licensing: analyst
FierceBiotech 24. Feb. 2026 Evinova reels in AI clinical development deals with Astellas and AstraZeneca
FierceBiotech 24. Feb. 2026 GSK explores frontiers of siRNA with $1B deal for 2 drugs from Chinese biotech
FierceBiotech 24. Feb. 2026 Labcorp, PathAI expand partnership to offer AI tech for digital pathology diagnostics
FierceBiotech 24. Feb. 2026 Allurion stock balloons as FDA signs off on its weight loss gastric system